| Short Descr | Malposition of heart |
| HHS-HCC v03 (ACA) | 138 - Major Congenital Heart/Circulatory Disorders |
| HHS-HCC v04 (ACA) | 138 - Major Congenital Heart/Circulatory Disorders |
|
Code
|
Description
|
|---|---|
| A4641 | Radiopharmaceutical, diagnostic, not otherwise classified |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose |
| A9501 | Technetium tc-99m teboroxime, diagnostic, per study dose |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose |
| A9505 | Thallium tl-201 thallous chloride, diagnostic, per millicurie |
| A9526 | Nitrogen n-13 ammonia, diagnostic, per study dose, up to 40 millicuries |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries |
| A9700 | Supply of injectable contrast material for use in echocardiography, per study |
| C8921 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete |
| C8922 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; follow-up or limited study |
| C8923 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography |
| C8924 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study |
| C8925 | Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, real time with image documentation (2d) (with or without m-mode recording); including probe placement, image acquisition, interpretation and report |
| C8926 | Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; including probe placement, image acquisition, interpretation and report |
| C8927 | Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for monitoring purposes, including probe placement, real time 2-dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis |
| C8928 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
| C8930 | Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report |
| G0404 | Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination |
| G0405 | Electrocardiogram, routine ecg with 12 leads; interpretation and report only, performed as a screening for the initial preventive physical examination |
| J0151 | Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) [deleted] |
| J0152 | Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) [deleted] |
| J0395 | Injection, arbutamine hcl, 1 mg |
| J1245 | Injection, dipyridamole, per 10 mg |
| J1250 | Injection, dobutamine hydrochloride, per 250 mg |
| R0076 | Transportation of portable ekg to facility or location, per patient |
| No matching codes found | |